UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Enhancing Strategies for CRISPR/Cas9 Based T cell Engineering

Preece, Roland; (2020) Enhancing Strategies for CRISPR/Cas9 Based T cell Engineering. Doctoral thesis (Ph.D), UCL (University College London). Green open access

[thumbnail of Preece_10106502_thesis_redacted.pdf]
Preview
Text
Preece_10106502_thesis_redacted.pdf

Download (11MB) | Preview

Abstract

Genome editing tools are being rapidly developed, accelerating many areas of cell and gene therapy research, and are now entering clinical phase testing. Each successive genome editing technology promises increased efficacy, improved specificity, reduced manufacturing cost and design complexity; all of which are epitomised by the clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas9) platform. Implementation of CRISPR/Cas9 in existing methodologies has been instrumental to recent progress in the treatment of cancer, primary immunodeficiency, and infectious diseases. To this end, T cell therapies attempting to redirect antigen recognition have been enhanced through CRISPR/Cas9 genome editing, endowing them with increased potency and persistence, as well as allowing the generation of allogeneic products capable of overcoming barriers to transplant. This project aims to improve CRISPR/Cas9 strategies for T cell engineering through the development of a novel self-inactivating lentiviral vector platform (terminal-CRISPR) that couples expression of CRISPR single guide RNA (sgRNA) and transgene expression, through incorporation of a sgRNA expression cassette within the ΔU3 region of the 3’ long terminal repeat sequence. Initial investigation coupled expression of a chimeric antigen receptor and a T cell receptor alpha constant specific sgRNA, resulting in CAR+ cells devoid of alloreactive T cell receptor (TCR)αβ complexes. Moreover edited TCRαβ-/CAR+ effectors demonstrated enhanced anti-leukemic outcomes in an in vivo tumour model. The terminal-CRISPR configuration further provided a platform for exploring the architecture of the U6 promoter, enabling the discovery of a minimal U6 promoter, which has been applied to the optimisation of a multiplex terminal-CRISPR vector. Moreover, concerns surrounding the generation of double strand DNA breaks prompted the application of emerging cytidine deaminase base editing technologies, showing high levels of targeted base conversions at multiple genomic loci, while also reducing large chromosomal translocation events. The terminal-CRISPR platform was further proved effective at linking delivery of a Hepatitis B virus specific recombinant TCR and sgRNA for disruption of the endogenous TCR. Discriminatory enrichment of antigen specific T cells with removal of the endogenous TCR offers an enhanced, highly targeted T cell therapy. This strategy is currently under evaluation for application in phase 1 clinical testing targeting B cell malignancies.

Type: Thesis (Doctoral)
Qualification: Ph.D
Title: Enhancing Strategies for CRISPR/Cas9 Based T cell Engineering
Event: UCL
Open access status: An open access version is available from UCL Discovery
Language: English
Additional information: Copyright © The Author 2020. Original content in this thesis is licensed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) Licence (https://creativecommons.org/licenses/by/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request.
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10106502
Downloads since deposit
455Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item